MANULIFE FINANCIAL CORP

Manulife has announced pricing for a public offering of $750 million subordinated notes due September 11, 2041. The notes are being issued at par and pay a fixed rate of 6.146% until September 11, 2036; thereafter the rate will reset to the CMT rate plus 1.350% until final maturity. The securities are intended to qualify as regulatory Tier-2 capital and are callable under certain conditions and subject to approval by the Superintendent of Financial Institutions. Net proceeds are for general corporate purposes, including possible refinancing; BofA Securities, Citigroup, J.P. Morgan and Morgan Stanley are acting as joint book‑running managers. » Más en de.investing.com

Manulife reported Q2 APE sales up 21%, core earnings up 12% and core EPS up 16%, driven by record Asia results and CAD 4 billion of global wealth-management net inflows. Canadian APE rose 23% but Canadian core earnings fell 10% due to unfavorable group and disability claims; management expects insurance experience to trend toward neutral by end-2026 and can reprice group business. The company agreed with Munich Re to cede 80% of biometric risk on CAD 3.2 billion of long-term care reserves, reducing long-term care morbidity risk by 24% overall. Manulife ended the quarter with a 136% LICAT ratio, returned CAD 1.4 billion to shareholders in the quarter and reiterated capital and ROE targets. » Más en finance.yahoo.com

Manulife has declared a quarterly dividend of 0.485 CAD per common share, payable on September 21, 2026 to shareholders of record at the close of business on August 21, 2026. The company intends to purchase common shares on the open market under its Canadian and U.S. dividend reinvestment and share purchase plan; the purchase price will be based on the average actual acquisition costs without discounts. » Más en de.investing.com